July 29, 2024 Second-quarter highlights Group sales amounted to EUR 4.5 billion, with comparable sales growth of 2% Comparable order intake increased by 9% Income from operations EUR 816 million, including EUR 538 million insurance income*) Adjusted EBITA margin increased to 11.1% of sales Operating cash inflow of EUR 89 million, with a free cash [...]
SHANGHAI, July 26, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, and its wholly-owned subsidiary TopAlliance Biosciences Inc. (TopAlliance Biosciences), announce that the Committee for Medicinal Products for Human Use (CHMP) of the [...]
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Sandoz launches biosimilar Pyzchiva® (ustekinumab) across Europe, to treat chronic inflammatory diseases Launch across Europe, starting today, strengthens well-established Sandoz immunology portfolio in Europe, leveraging existing footprint Pyzchiva® first ustekinumab biosimilar to launch in Europe with all reference medicine strengths, including 130mg vial initiation [...]
KUALA LUMPUR, Malaysia, July 24, 2024 (Korea Bizwire) – Malaysia Healthcare Travel Council (MHTC) is proud to announce the premiere of EMH Stories, a limited-series video production showcasing the exceptional experience of the healthcare journey of healthcare professionals, patients and technology breakthrough within Malaysia’s healthcare travel ecosystem. Experience Malaysia Healthcare (EMH) Stories is designed to provide an [...]
Prota Therapeutics appoints Patrick Machado as Chair to its Board of Directors. Patrick has a successful 30-year track record in biotech across North America and Europe Patrick is motivated by Prota’s mission to develop a peanut allergy treatment due to its potential to improve patient lives, especially for children and their families MELBOURNE, Australia, July [...]
Self-care describes the role of individuals in preventing disease, promoting and maintaining their mental and physical health, and actively participating in their healthcare A wealth of evidence demonstrates the significant value of self-care to individuals, health systems, society and the economy Despite this, self-care is not universally viewed or understood as a healthcare intervention and [...]
Through the power of data, Tealium’s new solution solves healthcare companies’ biggest CX and regulatory compliance challenges San Diego, July 23, 2024 (Korea Bizwire) – Tealium, the largest independent and most trusted customer data platform (CDP), has released Tealium for Healthcare, a new solution that empowers healthcare organizations with stronger data governance, allowing them to gain deeper [...]
VANCOUVER, British Columbia, July 22, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that the United States Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for ZW191, [...]
Ladies and Gentlemen, We cordially invite you to the online Half-Year Results Conference 2024 of Ascom Holding AG. There are two ways to participate in our conference: A conference call will be set up where analysts and media representatives can ask questions after the presentation. In addition, a live audio webcast with synchronized presentation slides including Q&A will be available. Date: Tuesday 6 August [...]
Milestones reached in cardiovascular, renal, metabolic health (CRM), and oncology Further data read-outs expected in 2024 in oncology, mental health, and pulmonary fibrosis Strong first half net sales growth of 7.4%* year on year Boehringer Ingelheim, a leading research-driven biopharmaceutical company, reported on Thursday significant progress in its pipeline across key therapeutic areas as it [...]